Platelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target

References

• From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015. Available from: www.goldcopd.org/ [Last accessed 26 January 2015]
   Google Scholar
• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28(3):523-32
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442
   PubMed Web of Science ®Google Scholar
• Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the burden of obstructive lung disease (BOLD) study. Med J Aust 2013;198(3):144-8
   PubMed Web of Science ®Google Scholar
• Habraken JM, ter Riet G, Gore JM, et al. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain Symptom Manage 2009;37(6):973-81
   Google Scholar
• Pasquale MK, Sun SX, Song F, et al. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis 2012;7:757-64
   PubMed Web of Science ®Google Scholar
• van Dam van Isselt Eé F, Groenewegen-Sipkema KH, Spruit-van Eijk M, et al. Pain in patients with COPD: a systematic review and meta-analysis. BMJ Open 2014;4:9
   Google Scholar
• Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61(11):935-9
   PubMed Web of Science ®Google Scholar
• Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD?–Report from the obstructive lung disease in northern sweden studies. Respir Med 2003;97:115-22
   PubMed Web of Science ®Google Scholar
• Kurmi OP, Lam KB, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 2012;40(1):239-54
   PubMed Web of Science ®Google Scholar
• Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med 2014;2:823-60
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693-718
   PubMed Web of Science ®Google Scholar
• Kodgule R, Salvi S. Exposure to biomass smoke as a cause for airway disease in women and children. Curr Opin Allergy Clin Immunol 2012;12:82-90
   PubMed Web of Science ®Google Scholar
• Kew KM and Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;3:Cd010115
   Google Scholar
• Vollenweider Daniela J, Jarrett H, Steurer-Stey Claudia A, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;12:CD010257
   Google Scholar
• Sohal SS, Ward C, Danial W, et al. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease. Expert Rev Respir Med 2013;7:275-88
   PubMed Web of Science ®Google Scholar
• Sohal SS, Eapen MS, Shukla SS, et al. Novel insights into chronic obstructive pulmonary disease (COPD): an overview. EMJ Respir 2014;2:81-7
   Google Scholar
• Hogg JC, McDonough JE, Sanchez PG, et al. Micro–Computed tomography measurements of peripheral lung pathology in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:546-9
   PubMedGoogle Scholar
• MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc 2009;6:527-31
   PubMedGoogle Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53
   PubMed Web of Science ®Google Scholar
• Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:478-85
   PubMedGoogle Scholar
• Hogg JC, Chu FS, Tan WC, et al. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med 2007;176:454-9
   PubMed Web of Science ®Google Scholar
• Robinson J. Colonization and infection of the respiratory tract: What do we know? Paediatr Child Health 2004;9:21-4
   PubMedGoogle Scholar
• Banerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004;23:685-91
   PubMed Web of Science ®Google Scholar
• Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997;10:1137-44
   PubMed Web of Science ®Google Scholar
• Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012;67:1075-80
   PubMed Web of Science ®Google Scholar
• Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015-22
   PubMed Web of Science ®Google Scholar
• Hill AT, Campbell EJ, Hill SL, et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288-95
   PubMed Web of Science ®Google Scholar
• Sethi S, Maloney J, Grove L, et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:991-8
   PubMed Web of Science ®Google Scholar
• Sethi S, Wrona C, Grant BJ, et al. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:448-53
   PubMed Web of Science ®Google Scholar
• Weinreich UM, Korsgaard J. Bacterial colonisation of lower airways in health and chronic lung disease. Clin Respir J 2008;2:116-22
   Google Scholar
• Desai H, Eschberger K, Wrona C, et al. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014;11:303-9
   PubMedGoogle Scholar
• Wilkinson TM, Patel IS, Wilks M, et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-5
   PubMed Web of Science ®Google Scholar
• Marin A, Garcia-Aymerich J, Sauleda J, et al. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 2012;9:121-30
   PubMedGoogle Scholar
• Beasley V, Joshi PV, Singanayagam A, et al. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis 2012;7:555-69
   PubMed Web of Science ®Google Scholar
• Marin A, Monso E, Garcia-Nunez M, et al. Variability and effects of bronchial colonisation in patients with moderate COPD. Eur Respir J 2010;35:295-302
   PubMed Web of Science ®Google Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-23
   PubMed Web of Science ®Google Scholar
• Borg I, Rohde G, Loseke S, et al. Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J 2003;21:944-51
   PubMed Web of Science ®Google Scholar
• Falsey AR, Formica MA, Hennessey PA, et al. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:639-43
   PubMed Web of Science ®Google Scholar
• McManus TE, Marley AM, Baxter N, et al. Acute and latent adenovirus in COPD. Respir Med 2007;101:2084-90
   PubMed Web of Science ®Google Scholar
• Kasuga I, Hogg JC, Paré PD, et al. Role of genetic susceptibility to latent adenoviral infection and decreased lung function. Respir Med 2009;103:1672-80
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Espinosa C, Fernandez-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1996;116:40-6
   Google Scholar
• Rosell A, Monsó E, Soler N, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005;165:891-7
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax 2006;61:250-8
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31
   PubMed Web of Science ®Google Scholar
• Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-64
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52
   PubMed Web of Science ®Google Scholar
• Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001;14:336-63
   PubMed Web of Science ®Google Scholar
• Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 2010;15:536-42
   PubMed Web of Science ®Google Scholar
• Hershenson MB. Rhinovirus-induced exacerbations of asthma and COPD. Scientifica 2013;2013:405876
   PubMedGoogle Scholar
• Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990;142:1004-8
   PubMed Web of Science ®Google Scholar
• Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-505
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71
   PubMed Web of Science ®Google Scholar
• Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:1117-24
   PubMed Web of Science ®Google Scholar
• Kline KA, Falker S, Dahlberg S, et al. Bacterial adhesins in host-microbe interactions. Cell Host Microbe 2009;5:580-92
   PubMed Web of Science ®Google Scholar
• Pizarro-Cerda J, Cossart P. Bacterial adhesion and entry into host cells. Cell 2006;124:715-27
   PubMed Web of Science ®Google Scholar
• Grigg J. The platelet activating factor receptor: a new anti-infective target in respiratory disease? Thorax 2012;67:840-1
   Google Scholar
• Cundell DR, Gerard NP, Gerard C, et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995;377:435-8
   PubMed Web of Science ®Google Scholar
• Swords WE, Buscher BA, Ver Steeg Ii K, et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 2000;37:13-27
   PubMed Web of Science ®Google Scholar
• Iovino F, Brouwer MC, van de Beek D, et al. Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease. Cell Microbiol 2013;15:870-81
   Google Scholar
• Clementi C, Murphy T. Nontypeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol. 2011;1:1
   Google Scholar
• Shukla SD. Platelet-activating factor receptor and signal transduction mechanisms. Faseb j 1992;6:2296-301
   PubMed Web of Science ®Google Scholar
• Izumi T, Shimizu T. Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta 1995;1259:317-33
   PubMed Web of Science ®Google Scholar
• Nakamura M, Honda Z, Izumi T, et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991;266:20400-5
   PubMed Web of Science ®Google Scholar
• Chen C, Xia SH, Chen H, et al. Therapy for acute pancreatitis with platelet-activating factor receptor antagonists. World J Gastroenterol 2008;14:4735-8
   PubMed Web of Science ®Google Scholar
• Cabellos C, MacIntyre DE, et al. Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. J Clin Invest 1992;90:612-18
   PubMed Web of Science ®Google Scholar
• Sagara H, Fukuda T, Okada T, et al. Theophylline at therapeutic concentration suppresses PAF-induced upregulation of Mac-1 on human eosinophils. Clin Exp Allergy 1996;26(Suppl 2):16-21
   Google Scholar
• Soliman A, Michelsen KS, Karahashi H, et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS One 2010;5(10):e15044
   Google Scholar
• Mosser DM. Receptors on phagocytic cells involved in microbial recognition. Immunol Ser 1994;60:99-114
   Google Scholar
• Forsgren J, Samuelson A, Ahlin A, et al. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun 1994;62:673-9
   PubMed Web of Science ®Google Scholar
• St Geme JW, Falkow S. Haemophilus influenzae adheres to and enters cultured human epithelial cells. Infect Immun 1990;58:4036-44
   PubMed Web of Science ®Google Scholar
• Berenson CS, Garlipp MA, Grove LJ, et al. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006;194:1375-84
   PubMed Web of Science ®Google Scholar
• Berenson CS, Wrona CT, Grove LJ, et al. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med 2006;174:31-40
   PubMed Web of Science ®Google Scholar
• Berenson CS, Kruzel RL, Eberhardt E, et al. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease. J Infect Dis 2013;208:2036-45
   PubMed Web of Science ®Google Scholar
• Clark SE, Weiser JN. Microbial modulation of host immunity with the small molecule phosphorylcholine. Infect Immun 2013;81:392-401
   Google Scholar
• Thornton JA, Durick-Eder K, Tuomanen EI. Pneumococcal pathogenesis: “innate invasion” yet organ-specific damage. J Mol Med 2010;88:103-7
   Google Scholar
• Van Eldere J, Slack MP, Ladhani S, et al. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis 2014;14:1281-92
   PubMed Web of Science ®Google Scholar
• Radin JN, Orihuela CJ, Murti G, et al. Beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun 2005;73:7827-35
   PubMed Web of Science ®Google Scholar
• Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998;102:347-60
   PubMed Web of Science ®Google Scholar
• Iovino F, Molema G, Bijlsma JJE. Streptococcus pneumoniae Interacts with pIgR Expressed by the Brain Microvascular Endothelium but Does Not Co-Localize with PAF Receptor. PLoS One 2014;9(5):e97914
   Google Scholar
• Ishizuka S, Yamaya M, Suzuki T, et al. Acid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expression. Am J Respir Cell Mol Biol 2001;24:459-68
   Google Scholar
• Mushtaq N, Ezzati M, Hall L, et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. J Allergy Clin Immunol 2011;127:1236-42.e1232
   PubMed Web of Science ®Google Scholar
• McCullers JA, Iverson AR, McKeon R, et al. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand J Infect Dis 2008;40:11-17
   PubMed Web of Science ®Google Scholar
• Shivshankar P, Boyd AR, Le Saux CJ, et al. Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell 2011;10:798-806
   PubMed Web of Science ®Google Scholar
• Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993;292:617-29
   PubMed Web of Science ®Google Scholar
• Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest 1997;111:1266-72
   PubMed Web of Science ®Google Scholar
• Murphy TF. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 2003;16:129-34
   PubMed Web of Science ®Google Scholar
• Geme JWS. Molecular and cellular determinants of non-typeable Haemophilus influenzae adherence and invasion. Cell Microbiol 2002;4:191-200
   Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65
   PubMed Web of Science ®Google Scholar
• Bandi V, Apicella MA, Mason E, et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001;164:2114-19
   PubMed Web of Science ®Google Scholar
• Weiser JN, Shchepetov M, Chong ST. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect Immun 1997;65:943-50
   PubMed Web of Science ®Google Scholar
• Clark SE, Snow J, Li J, et al. Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog 2012;8:e1002521
   PubMedGoogle Scholar
• Weiser JN, Pan N, McGowan KL, et al. Phosphorylcholine on the lipopolysaccharide of haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med 1998;187:631-40
   PubMedGoogle Scholar
• Schweda EK, Brisson JR, Alvelius G, et al. Characterization of the phosphocholine-substituted oligosaccharide in lipopolysaccharides of type b Haemophilus influenzae. Eur J Biochem 2000;267:3902-13
   Google Scholar
• McCrea KW, Xie J, Marrs CF, et al. Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus. BMC Microbiol 2010;10:286
   Google Scholar
• Weiser JN, Love JM, Moxon ER. The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 1989;59:657-65
   PubMed Web of Science ®Google Scholar
• Michel V, Yuan Z, Ramsubir S, et al. Choline transport for phospholipid synthesis. Exp Biol Med 2006;231:490-504
   PubMed Web of Science ®Google Scholar
• Fan X, Pericone CD, Lysenko E, et al. Multiple mechanisms for choline transport and utilization in haemophilus influenzae. Mol Microbiol 2003;50:537-48
   PubMedGoogle Scholar
• Craig JE, Cliffe A, Garnett K, et al. Survival of nontypeable haemophilus influenzae in macrophages. FEMS Microbiol Lett 2001;203:55-61
   PubMed Web of Science ®Google Scholar
• Fischer W, Behr T, Hartmann R, et al. Teichoic acid and lipoteichoic acid of streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide). Eur J Biochem 1993;215:851-7
   PubMedGoogle Scholar
• Swords WE, Ketterer MR, Shao J, et al. Binding of the non-typeable haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol 2001;3:525-36
   PubMed Web of Science ®Google Scholar
• Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol 2008;295:L231-4
   PubMed Web of Science ®Google Scholar
• Hinojosa E, Boyd AR, Orihuela CJ. Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis 2009;200:546-54
   PubMed Web of Science ®Google Scholar
• Rijneveld AW, Weijer S, Florquin S, et al. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004;189(4):711-16
   PubMed Web of Science ®Google Scholar
• van der Sluijs KF, van Elden LJ, Nijhuis M, et al. Involvement of the platelet-activating factor receptor in host defense against streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol 2006;290(1):L194-9
   PubMed Web of Science ®Google Scholar
• Branger J, Wieland CW, Florquin S, et al. Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract. Shock 2004;22(6):543-7
   Google Scholar
• Shirasaki H, Nishikawa M, Adcock IM, et al. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. Ame J Respir Cell Mol Bio 1994;10:533-7
   Google Scholar
• Grigg J, Walters H, Sohal SS, et al. Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells. Thorax 2012;67:908-13
   Google Scholar
• Suri R, Mallia P, Martin JE, et al. Bronchial platelet-activating factor receptor in chronic obstructive pulmonary disease. Respir Med 2014;108:898-904
   PubMed Web of Science ®Google Scholar
• Shukla SD, Sohal SS, Mahmood MQ, et al. Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:853-61
   Web of Science ®Google Scholar
• Ishizuka S, Yamaya M, Suzuki T, et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis 2003;188:1928-39
   PubMed Web of Science ®Google Scholar
• Wang JH, Kwon HJ, Jang YJ. Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously. Laryngoscope 2009;119:1406-11
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89
   PubMed Web of Science ®Google Scholar
• Cates C. Inhaled corticosteroids in COPD: quantifying risks and benefits. Thorax 2013;68:499-500
   Google Scholar
• Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34:641-7
   PubMed Web of Science ®Google Scholar
• Singh R, Mackay AJ, Patel AR, et al. Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease. Respir Res 2014;15:114
   PubMed Web of Science ®Google Scholar
• Hwang SB, Lam MH, Alberts AW, et al. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. J Pharma Exp Therap 1988;246:534-41
   PubMed Web of Science ®Google Scholar
• Ponpipom MM, Hwang SB, Doebber TW, et al. (+/-)-trans-2-(3-Methoxy-z5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. Biochem Biophys Res Commun 1988;150:1213-20
   PubMed Web of Science ®Google Scholar
• Arnout J, van Hecken A, De Lepeleire I, et al. Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man. Br J Clin Pharmacol 1988;25:445-51
   PubMed Web of Science ®Google Scholar
• Adamus WS, Heuer HO, Meade CJ, et al. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings. Clin Pharm Therap 1990;47:456-62
   PubMed Web of Science ®Google Scholar
• Bandi V, Jakubowycz M, Kinyon C, et al. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable haemophilus influenzae. FEMS Immunol Med Microbiol 2003;37:69-75
   PubMed Web of Science ®Google Scholar
• Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc 2004;1:109-14
   PubMedGoogle Scholar
• Barbier M, Agusti A, Alberti S. Fluticasone propionate reduces bacterial airway epithelial invasion. Eur Respir J 2008;32(5):1283-8
   PubMed Web of Science ®Google Scholar